Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 009218
Company: BRISTOL MYERS SQUIBB
Company: BRISTOL MYERS SQUIBB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
COUMADIN | WARFARIN SODIUM | 10MG | TABLET;ORAL | Discontinued | None | Yes | No |
COUMADIN | WARFARIN SODIUM | 5MG | TABLET;ORAL | Discontinued | None | Yes | No |
COUMADIN | WARFARIN SODIUM | 75MG/VIAL | INJECTABLE;INJECTION | Discontinued | None | No | No |
COUMADIN | WARFARIN SODIUM | 2MG | TABLET;ORAL | Discontinued | None | Yes | No |
COUMADIN | WARFARIN SODIUM | 7.5MG | TABLET;ORAL | Discontinued | None | Yes | No |
COUMADIN | WARFARIN SODIUM | 2.5MG | TABLET;ORAL | Discontinued | None | Yes | No |
COUMADIN | WARFARIN SODIUM | 50MG/VIAL | INJECTABLE;INJECTION | Discontinued | None | No | No |
COUMADIN | WARFARIN SODIUM | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL | Discontinued | None | Yes | No |
COUMADIN | WARFARIN SODIUM | 4MG | TABLET;ORAL | Discontinued | None | Yes | No |
COUMADIN | WARFARIN SODIUM | 5MG/VIAL | INJECTABLE;INJECTION | Discontinued | None | No | No |
COUMADIN | WARFARIN SODIUM | 3MG | TABLET;ORAL | Discontinued | None | Yes | No |
COUMADIN | WARFARIN SODIUM | 6MG | TABLET;ORAL | Discontinued | None | Yes | No |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
08/14/2017 | SUPPL-118 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009218s118lbl.pdf | |
08/14/2017 | SUPPL-118 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009218s118lbl.pdf | |
05/22/2017 | SUPPL-117 | Labeling-Patient Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009218s017lbl.pdf | |
05/22/2017 | SUPPL-117 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009218s017lbl.pdf | |
09/08/2016 | SUPPL-116 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/009218s116lbl.pdf | |
10/28/2015 | SUPPL-115 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/009218s115lbl.pdf | |
10/28/2015 | SUPPL-115 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/009218s115lbl.pdf | |
10/04/2011 | SUPPL-107 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/009218s107lbl.pdf | |
01/22/2010 | SUPPL-108 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/009218s108lbl.pdf | |
08/16/2007 | SUPPL-105 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/009218s105lblv2.pdf | |
10/04/2006 | SUPPL-102 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/009218s102lbl.pdf | |
09/02/2005 | SUPPL-101 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/009218s101lbl.pdf |